AA
Therapeutic Areas
Gulf Pharmaceutical Industries Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Insulin Glargine (Biosimilar) | Diabetes | Approved/Commercial |
| Branded Generics Portfolio | Multiple (Diabetes, CVS, GI, etc.) | Approved/Commercial |
| OTC Product Portfolio | Pain, Cough & Cold, Nutritionals | Approved/Commercial |
| Biosimilar Candidates | Oncology, Autoimmune Diseases | Pre-clinical |
Leadership Team at Gulf Pharmaceutical Industries
DE
Dr. Essam Mohammed
Chief Executive Officer
SS
Sheikh Saqer Humaid Al Qasimi
Chairman of the Board
MA
Mohammed Abdulla Al Jaziri
Board Member
AA
Abdulla Abduljalil Al Fardan
Board Member
JS
Jeremy S. Suddrey
Chief Financial Officer
DN
Dr. Nizar Hemmo
Chief Regulatory & Pharmacovigilance Officer
DF
Dr. Faisal A. Al Nawais
Chief Corporate Affairs Officer
DA
Dr. Ayman H. Abdel Malak
Chief Business Officer
DT
Dr. Tamer El Kady
Chief Commercial Officer
DA
Dr. Ahmed El Hadi
Chief Human Resources Officer